₹8399.35
0.53%
Low
Day's Volatility:2.00%
High
1.47%
35.71%
Low
52 Weeks Volatility:47.38%
High
11.68%
Returns % | |
1 Month Return | 7.54 % |
3 Month Return | 0.54 % |
1 Year Return | 41.15 % |
Market Stats | |
Previous Close | ₹8,505.30 |
Open | ₹8,480.60 |
Volume | 19.06K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹19,343.70Cr |
based on 5 analysts
Based on 5 analysts offering long term price targets for Sanofi India Ltd. An average target of ₹9497.6
Source: S&P Global Market Intelligence
Organisation | Sanofi India Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Sanofi India Ltd
Sanofi India (NSE:SANOFI) announces a dividend payout of Rs 117.00, with a yield of 2%. EPS is expected to grow by 31.4% in the next year. The company's dividend history has been unstable, but dividends have grown rapidly.
Sanofi India Ltd Up 1.15% on NSE - 04 Apr, 2024
Sanofi India Ltd stock is up 1.15% on the NSE, trading at Rs 8742.2 as of 12:49 IST. The stock has gained 49.22% in the last year compared to a 28.03% gain in NIFTY and a 56.77% gain in the Nifty Pharma index. The PE ratio based on TTM earnings ending December 23 is 31.66.
Sanofi India Ltd Stock Up 0.46% on NSE - 01 Apr, 2024
Sanofi India Ltd stock is up 0.46% on the NSE, trading at Rs 8151.5 as of 12:44 IST. The stock has gained 40.71% in the last year compared to a 29.18% gain in NIFTY and a 58.96% gain in the Nifty Pharma.
Sanofi India to Pay Dividend of ₹117.00 per Share - 29 Mar, 2024
Sanofi India Limited will pay a dividend of ₹117.00 per share on June 13, which is above the industry average and represents 2.1% of the current stock price. While earnings are expected to expand by 31.4%, the last payment made up 196% of cash flows, indicating that the company may be more focused on returning cash flow to shareholders than retaining it for future growth.
Cipla Partners with Sanofi India for CNS Product Range Distribution - 27 Mar, 2024
Sanofi India has signed an exclusive partnership with Cipla for the distribution and promotion of its Central Nervous System (CNS) product range, including six brands such as Frisium®, a leading anti-epileptic drug. Cipla will handle the distribution of these products in India.
Sanofi India Partners with Cipla for CNS Product Line Distribution - 26 Mar, 2024
Sanofi India has entered into an exclusive distribution and marketing partnership with Cipla Limited to expand the reach of its Central Nervous System (CNS) product line in India. As part of this collaboration, Cipla will handle the distribution of Sanofi India's six CNS brands.
Sanofi India Signs Distribution Agreement with Emcure Pharmaceuticals - 14 Mar, 2024
Sanofi India has approved an exclusive distribution and promotion agreement with Emcure Pharmaceuticals for its cardiovascular products in India. Emcure will exclusively distribute and promote Sanofi's well-established brands like Cardace, Clexane, Targocid, Lasix, and Lasilactone.
Fundamentals of Sanofi India Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 9.97% to 11.51% in Dec 2023 quarter
Price Rise
In the last 3 years, SANOFI stock has moved up by 8.4%
Against Peers
In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 54.0% return, outperforming this stock by 12.8%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 60.40% of holdings in Dec 2023 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 140.0% return, outperforming this stock by 131.6%
FII Holding Down
Foreign Institutions have decreased holdings from 6.80% to 6.31% in Dec 2023 quarter
Retail Holding Down
Retail Investor have decreased holdings from 11.11% to 10.58% in Dec 2023 quarter
Sanofi India Ltd in the last 5 years
Lowest (0.00x)
December 29, 2023
Today (32.07x)
April 16, 2024
Industry (60.97x)
April 16, 2024
Highest (35.16x)
February 22, 2024
Funds | Holdings |
Aditya Birla Sun Life Frontline Equity Fund Direct Plan Growth | 0.83% |
Nippon India Pharma Fund - Direct Plan - Growth Plan | 2.69% |
Nippon India Growth Fund - Direct Plan - Growth | 0.74% |
Nippon India Small Cap Fund - Direct Plan - Growth Plan | 0.38% |
SBI Contra Fund Direct Growth | 0.49% |
Investors | Holdings % | Prev. 4 periods | 3M change |
---|---|---|---|
Promoter Holdings | 60.4% | 0.00 | |
Foreign Institutions | 6.31% | ||
Mutual Funds | 11.51% | 15.44 | |
Retail Investors | 10.58% | ||
Others | 11.2% |
Technicals of Sanofi India Ltd share
News & Events of Sanofi India Ltd
Sanofi India Ltd (SANOFI) share price today is ₹8399.35
Sanofi India Ltd is listed on NSE
Sanofi India Ltd is listed on BSE
PE Ratio of Sanofi India Ltd is 32.07
PE ratio = Sanofi India Ltd Market price per share / Sanofi India Ltd Earnings per share
Today’s traded volume of Sanofi India Ltd(SANOFI) is 19.06K.
Today’s market capitalisation of Sanofi India Ltd(SANOFI) is ₹19343.7Cr.
Sanofi India Ltd(SANOFI | Price |
---|---|
52 Week High | ₹9380 |
52 Week Low | ₹5400 |
Sanofi India Ltd(SANOFI) share price is ₹8399.35. It is down -10.45% from its 52 Week High price of ₹9380
Sanofi India Ltd(SANOFI) share price is ₹8399.35. It is up 55.54% from its 52 Week Low price of ₹5400
Sanofi India Ltd(SANOFI | Returns |
---|---|
1 Day Returns | -105.95% |
1 Month Returns | 7.54% |
3 Month Returns | 0.54% |
1 Year Returns | 41.15% |